774 related articles for article (PubMed ID: 16459415)
1. Legal and ethical issues associated with patient recruitment in clinical trials: the case of competitive enrolment.
Caulfield T
Health Law Rev; 2005; 13(2-3):58-61. PubMed ID: 16459415
[No Abstract] [Full Text] [Related]
2. Bounty-hunting and finder's fees.
Christensen JA; Orlowski JP
IRB; 2005; 27(3):16-9. PubMed ID: 16021797
[No Abstract] [Full Text] [Related]
3. Conflict of interest in clinical research: direct payment to the investigators for finding human subjects and health information.
Puttagunta PS; Caulfield TA; Griener G
Health Law Rev; 2002; 10(2):30-2. PubMed ID: 15739309
[TBL] [Abstract][Full Text] [Related]
4. Conflict of interest in human subjects research.
Groeger JS; Barnes M
Crit Care Med; 2003 Mar; 31(3 Suppl):S137-42. PubMed ID: 12626959
[No Abstract] [Full Text] [Related]
5. Advertising for clinical research.
Miller FG; Schorr AF
IRB; 1999; 21(5):1-4. PubMed ID: 12625347
[No Abstract] [Full Text] [Related]
6. Is post-marketing drug follow-up research or advertising?
Weiss GB; Winslade WJ
IRB; 1987; 9(4):10-1. PubMed ID: 11649947
[No Abstract] [Full Text] [Related]
7. Conflicts of interest in medical research: how much conflict should exceed legal boundaries?
Klanica K
J Biolaw Bus; 2005; 8(3):37-45. PubMed ID: 16459426
[TBL] [Abstract][Full Text] [Related]
8. Incentivizing recruitment and retention to address enrollment challenges in clinical research.
Dickert NW; Halpern SD; Butler J
Circ Cardiovasc Qual Outcomes; 2013 May; 6(3):367-70. PubMed ID: 23652736
[No Abstract] [Full Text] [Related]
9. Putting the "ethics" into "research ethics".
Spike J
Am J Bioeth; 2005; 5(1):51-3; author reply W15-8. PubMed ID: 16036663
[No Abstract] [Full Text] [Related]
10. The case for per patient payments.
Lewis JP
IRB; 1988; 10(5):9. PubMed ID: 11650075
[No Abstract] [Full Text] [Related]
11. Stakeholder perspectives on ethical challenges in HIV vaccine trials in South Africa.
Essack Z; Koen J; Barsdorf N; Slack C; Quayle M; Milford C; Lindegger G; Ranchod C; Mukuka R
Dev World Bioeth; 2010 Apr; 10(1):11-21. PubMed ID: 19459900
[TBL] [Abstract][Full Text] [Related]
12. Disclosing clinical trial results: publicity, significance and independence.
Liao SM; Sheehan M; Clarke S
Am J Bioeth; 2009 Aug; 9(8):W3-5. PubMed ID: 19998144
[No Abstract] [Full Text] [Related]
13. Why I oppose drug company payment of physician/investigators on a per patient/subject basis.
Roizen R
IRB; 1988; 10(1):9-10. PubMed ID: 11658990
[No Abstract] [Full Text] [Related]
14. The problem with optimism in clinical trials.
Jansen LA
IRB; 2006; 28(4):13-9. PubMed ID: 17036434
[No Abstract] [Full Text] [Related]
15. Expanding disclosure of conflicts of interest: the views of stakeholders.
Brody BA; Anderson C; McCrary SV; McCullough L; Morgan R; Wray N
IRB; 2003; 25(1):1-8. PubMed ID: 12833897
[No Abstract] [Full Text] [Related]
16. The Wiley Protocol: an analysis of ethical issues.
Rosenthal MS
Menopause; 2008; 15(5):1014-22. PubMed ID: 18551081
[TBL] [Abstract][Full Text] [Related]
17. Competing clinical trials in the same institution: ethical issues in subject selection and informed consent.
Gordon EJ; Micetich KC
IRB; 2002; 24(2):1-7. PubMed ID: 12374154
[No Abstract] [Full Text] [Related]
18. Fast track to disaster? Considerations raised by the current recruitment techniques for clinical research subjects.
Isidor JM; Kaltman SP
J Biolaw Bus; 2002; 5(3):46-7. PubMed ID: 12816118
[TBL] [Abstract][Full Text] [Related]
19. Ethical considerations in informed consent for potential future use of human tissue samples.
Adams M; Prentice ED; Oki GS
IRB; 1996; 18(2):6-7. PubMed ID: 11654756
[No Abstract] [Full Text] [Related]
20. Why did Jesse die?
Walters J
Update; 2001 Nov; 17(2):E1. PubMed ID: 16130258
[No Abstract] [Full Text] [Related]
[Next] [New Search]
